BullFrog AI Holdings (BFRGW) Cash from Operations Growth (1y) (2023 - 2025)
Powered by 
Analysis
BullFrog AI Holdings (BFRGW) Cash from Operations Growth (1y) (2023 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.66 Bn | 197.67 Bn | 7.24 Bn | 75.53% |
| 2 | Gilead Sciences | 181.20 Bn | 178.03 Bn | 6.22 Bn | 332.04% |
| 3 | Vertex Pharmaceuticals | 132.30 Bn | 124.45 Bn | 2.84 Bn | 4.87% |
| 4 | Regeneron Pharmaceuticals | 82.63 Bn | 74.64 Bn | 3.93 Bn | -28.96% |
| 5 | Argenx Se | 61.60 Bn | 56.41 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.55 Bn | 49.41 Bn | 52.00 Mn | 42.76% |
| 7 | Alnylam Pharmaceuticals | 34.01 Bn | 30.71 Bn | 992.69 Mn | 151.70% |
| 8 | Biogen | 31.26 Bn | 29.97 Bn | 1.96 Bn | 178.99% |
| 9 | Roivant Sciences | 29.87 Bn | 29.87 Bn | 1.16 Mn | - |
| 10 | BullFrog AI Holdings | 1.84 Mn | -5.08 Mn | 106,899.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 6.84% |
| Sep 30, 2025 | 8.20% |
| Jun 30, 2025 | -16.37% |
| Mar 31, 2025 | 5.44% |
| Dec 31, 2024 | -24.95% |
| Sep 30, 2024 | 13.47% |
| Jun 30, 2024 | -0.19% |
| Mar 31, 2024 | 19.47% |
| Dec 31, 2023 | -2,467.77% |
| Sep 30, 2023 | -437.64% |
| Jun 30, 2023 | -103.94% |
| Mar 31, 2023 | -24,056.89% |